Bone scintigraphy screening in stage I-II breast cancer: Is it cost effective?

被引：0
|
作者：
Wikenheiser, KA [1 ]
Silberstein, EB [1 ]
机构：
[1] UNIV CINCINNATI, MED CTR, CINCINNATI, OH 45267 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 1996年 / 63卷 / 01期
关键词：
radionuclide imaging; breast neoplasms; bone neoplasms; cost-benefit analysis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraph should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.
引用
收藏
页码：43 / 47
页数：5
相关论文
共 50 条
  • [1] Serum Tumor Markers in Stage I-II Breast Cancer
    Tozzoli, Renato
    D'Aurizio, Federica
    Falcomer, Flavio
    Basso, Stefano M. M.
    Lumachi, Franco
    MEDICINAL CHEMISTRY, 2016, 12 (03) : 285 - 289
  • [2] Prognostic value of DNA ploidy in breast cancer Stage I-II
    Cufer, T
    Lamovec, J
    Bracko, M
    Lindtner, J
    UsKrasovec, M
    NEOPLASMA, 1997, 44 (02) : 127 - 132
  • [3] Breast-conserving therapy for stage I-II breast cancer in elderly women
    Cutuli, B
    Aristei, C
    Martin, C
    Perrucci, E
    Latini, P
    Quetin, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : 71 - 76
  • [4] Clinical value of screening for cytokeratin (CK)-positive bone marrow micrometastases in stage I-II cervical cancer
    Hepp, F
    Kentenich, CRM
    Janni, W
    Braun, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S230 - S230
  • [5] Bone marrow micrometastases in patients with stage I-II localised prostate cancer
    Vagunda, V
    Landys, K
    Kankkunen, JP
    Vagundova, M
    Hultborn, R
    Kovarik, J
    Hugosson, J
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (15) : 1847 - 1852
  • [6] Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients
    Mladenovic, J.
    Susnjar, S.
    Gavrilovic, D.
    Borojevic, N.
    JOURNAL OF BUON, 2007, 12 (02): : 215 - 220
  • [7] RECENT RESULTS IN ADJUVANT TRIALS FOR STAGE I-II BREAST-CANCER
    BONADONNA, G
    CANCER INVESTIGATION, 1986, 4 (05) : 500 - 501
  • [8] Locoregional recurrences after conservative treatment of breast cancer stage I-II
    Raspall, MJF
    Serra, EP
    Verdum, JI
    Muñoz, CA
    González, BO
    Gómez, AG
    Ollé, AL
    Pires, DD
    Puertas, EL
    de Grignon, JCBL
    López, AL
    Folch, MT
    MEDICINA CLINICA, 2002, 118 (05): : 161 - 165
  • [9] FOLLOW-UP OF BREAST-CANCER PATIENTS STAGE I-II
    CIATTO, S
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) : 1071 - 1071
  • [10] Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer
    Salihi, Rawand
    Leunen, Karin
    Moerman, Philippe
    Amant, Frederic
    Neven, Patrick
    Vergote, Ignace
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1256 - 1260
12345